Jennifer Lachey
2021
In 2021, Jennifer Lachey earned a total compensation of $2.7M as Chief Scientific Officer at Keros Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $201,400 |
|---|---|
| Option Awards | $2,101,166 |
| Salary | $402,800 |
| Other | $540 |
| Total | $2,705,906 |
Lachey received $2.1M in option awards, accounting for 78% of the total pay in 2021.
Lachey also received $201.4K in non-equity incentive plan, $402.8K in salary and $540 in other compensation.
Rankings
In 2021, Jennifer Lachey's compensation ranked 4,836th out of 12,415 executives tracked by ExecPay. In other words, Lachey earned more than 61.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,836 out of 12,415 | 61st |
Division Manufacturing | 2,022 out of 5,508 | 63rd |
Major group Chemicals And Allied Products | 855 out of 2,378 | 64th |
Industry group Drugs | 765 out of 2,099 | 64th |
Industry Pharmaceutical Preparations | 547 out of 1,549 | 65th |
Source: SEC filing on April 18, 2022.
Lachey's colleagues
We found two more compensation records of executives who worked with Jennifer Lachey at Keros Therapeutics in 2021.